Diagnosis and successful treatment of fusariosis in the compromised host

Journal of Infectious Diseases

Volumn 158, Issue 5, 1988, Pages 1046-1055

  Merz, William G ^a   Karp, Judith E ^a   Hoagland, Melissa ^a,b   Jett Goheen, Mary ^a   Junkins, Jacqueline M ^a   Hood, Antoinette F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE; MICONAZOLE;

ACUTE LEUKEMIA; CELLULITIS; CHEMOTHERAPY; DRUG RESISTANCE; FEMALE; FUNGEMIA; FUNGUS; FUSARIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN DEFECT;

ADULT; AMPHOTERICIN B; CASE REPORT; FEMALE; FLUCYTOSINE; FUSARIUM; HUMAN; IMMUNE TOLERANCE; LEUKEMIA; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, PROLYMPHOCYTIC; MALE; MIDDLE AGE; MYCOSES; OPPORTUNISTIC INFECTIONS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023796811     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/158.5.1046     Document Type: Article

References (69)

1. Bodey GP. Fungal infections complicating acute leukemia. J Chronic Dis 1966;19:667-87
2. Bodey GP. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986;80:112-9
3. Degregorio MW, Lee WMF, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med 1982;73:543-8
4. Gruhn JG, Sanson J. Mycotic infections in leukemic patients at autopsy. Cancer 1963;16:61-73
5. Karp JE, Merz WG. Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients. J Clin Oncol 1986;4:216-20
6. Mirsky HS, Cuttner J. Fungal infections in acute leukemia. Cancer 1972;30:348-52
7. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 1982; 72:101-11
8. Stein RS, Kayser J, Flexner JM. Clinical value of empirical amphotericin B in patients with acute myelogenous leukemia. Cancer 1982;50:2247-51
9. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 1984;53:411-9
10. Horn R, Wong B, Kiehn TE, Armstrong D. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy. Rev Infect Dis 1985;7:646-55
11. Lowder JN, Lazarus HM, Herzig RH. Bacteremias and funge-mias in oncologic patients with central venous catheters. Changing spectrum of infection. Arch Intern Med 1982; 142:1456-9
12. Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 1986;24:581-4
13. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Changing patterns, an-tigenemia, high mortality. Am J Med 1981;71:363-70
14. Sandford GR, Merz WG, Wingard JR, Charache P, Saral R. The value of fungal surveillance cultures as predictors of systemic fungal infections. J Infect Dis 1980;142:503-9
15. Rush-Munro FM, Black H, Dingley JM. Onychomycosis caused by Fusarium oxysporum. Aus J Derm 1971;12:18-29
16. Bourguignon RL, Walsh AF, Flynn JC, Baro C, Spinos E. Fusarium species osteomyelitis. Case report. J Bone Joint Surg 1976;58A:722-3
17. Bruck HM, Nash G, Stein JM, Lindberg RB. Studies on the occurrence and significance of yeasts and fungi in the burn wound. Ann Surg 1972;176:108-10
18. Collins MS, Rinaldi MG. Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia 1977;15:151-60
19. English MP. Invasion of the skin by filamentous non-dermatophyte fungi. Br J Dermatol 1968;80:282-6
20. English MP, Smith RJ, Harman RM. The fungal flora of ulcerated legs. Br J Dermatol 1971;84:567-81
21. Page JC, Friedlander G, Dockery GL. Postoperative Fusarium osteomyelitis. J Foot Surg 1982;21:174-6
22. Peterson JE, Baker TJ. An isolate of Fusarium roseum from human burns. Mycologia 1959;51:453-6
23. Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani. J Rheumatol 1983;10:151-3
24. Naumann G, Green WR, Zimmerman LE. Mycotic keratitis. A histopathologic study of 73 cases. Am J Ophthalmol 1967;64:668-82
25. Lieberman TW, Ferry AP, Bottone EJ. Fusarium solani endophthalmitis without primary corneal involvement. Am J Ophthalmol 1979;88:764-7
26. Rowsey JJ, Acers TE, Smith DL, Mohr JA, Newsom DL, Rodriguez J. Fusarium oxysporum endophthalmitis. Arch Ophthalmol 1979;97:103-5
27. Lazarus JA, Schwarz LH. Infestation of urinary bladder with an unusual fungus strain (Fusarium). The Urologie and Cutaneous Review 1948;52:185-9
28. Kerr CM, Perfect JR, Craven PC, Jorgensen JH, Drutz DJ, Shelburne JD, Gallis HA, Gutman RA. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med 1983;99:334-7
29. Ambramowsky CR, Quinn D, Bradford WD, Conant NF. Systemic infection by Fusarium in a burned child. The emergence of a saprophytic strain. J Pediatr 1974;84:561-4
30. Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM. Fusarium brain abscess. Case report. J Neurosurg 1983;58:598-601
31. Anaissie E, Kantarjian H, Jones P. Fungal infection caused by Fusarium in cancer patients. Am J Clin Oncol 1987;10:86-8
32. Anaissie E, Kantarjian H, Jones P, Barlogie B, Luna M, Lopez-Berenstein G, Bodey GP. Fusarium. A newly recognized fungal pathogen in immunosuppressed patients. Cancer 1986;57:2141-5
33. Anaissie E, Kantarjian H, Ro J, Hopfer R, Rolston K, Fain-stein V, Bodey G. The emerging role of Fusarium infections in patients with cancer. Medicine 1988;67:77-83
34. Blazar BR, Hurd DD, Snover DC, Alexander JW, McGlave PB. Invasive Fusarium infections in bone marrow transplant recipients. Am J Med 1984;77:645-51
35. Chaulk CP, Smith PW, Feagler JR, Verdirame J, Commers JR. Fungemia due to Fusarium solani in an immunocompromised child. Pediatr Infect Dis 1986;5:363-6
36. Cho CT, Vats TS, Lowman JT, Brandsberg JW, Tosh FE. Fusarium solani infection during treatment for acute leukemia. J Pediatr 1973;83:1028-31
37. June CH, Beatty PG, Shulman HM, Rinaldi MG. Disseminated Fusarium moniliforme infection after allogeneic marrow transplantation. South Med J 1986;41:47-51
38. Kiehn TE, Nelson PE, Bernard EM, Edwards FF, Koziner B, Armstrong D. Catheter-associated fungemia caused by Fusarium chlamydosporum in a patient with lymphocytic lymphoma. J Clin Microbiol 1985;21:501-4
39. Matsuda T, Matsumoto T. Disseminated hyalohyphomyco-sis in a leukemic patient. Arch Dermatol 1986;122:1171-5
40. Mutton KJ, Lucas TJ, Harkness JL. Disseminated Fusarium infection. Med J Aust 1980;2:624-5
41. Okuda C, Ito M, Sato Y, Oka K, Hotchi M. Disseminated cutaneous Fusarium infection with vascular invasion in a leukemic patient. J Med Vet Mycol 1987;25:177-86
42. Summerbell RC, Richardson SE, Kane J. Fusariumprolifer-atum as an agent of disseminated infection in an im-munosuppressed patient. J Clin Microbiol 1988;26:82-7
43. Veglia KS, Marks VJ. Fusarium as a pathogen. A case report of Fusarium sepsis and review of the literature. J Am Acad Dermatol 1987;16:260-3
44. Young NA, Kwon-Chung KJ, Kubota TT, Jennings AE, Fisher RI. Disseminated infection by Fusarium moniliforme during treatment for malignant lymphoma. J Clin Microbiol 1978;7:589-94
45. Gutmann L, Chou SM, Pore RS. Fusariosis, myasthenic syndrome, and aplastic anemia. Neurology 1975;25:922-6
46. Wheeler MS, McGinnis MR, Schell WA, Walker DH. Fusarium infection in burned patients. Am J Clin Pathol 1981;75:304-11
47. Vaughan WP, Karp JE, Burke PJ. Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia. Blood 1984;64:975-80
48. Merz WG, Fay D, Thumar B, Dixon D. Susceptibility testing of filamentous fungi to amphotericin B by a rapid radiometric method. J Clin Microbiol 1984;19:54-6
49. Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol 1987;5:1985-93
50. Donehower RC, Karp JE, Burke PJ. Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusion. Cancer Treat Rep 1986;70:1059-65
51. Burke PJ, Vaughan WP, Karp JE, Saylor PL. The correlation of maximal drug dose, tumor recruitment, and sequence timing with therapeutic advantage: Schedule-dependent toxicity of cytosine arabinoside. Med Pediatr Oncol 1982;10(Suppl l):201-8
52. Dosik GM, Luna M, Valdivieso M, McCredie KB, Gehan EA, Gil-Extremera B, Smith TL, Bodey GP. Necrotizing colitis in patients with cancer. Am J Med 1979;67:646-56
53. Prolla JC, Kirsner JB. The gastrointestinal lesions and complications of the leukemias. Ann Intern Med 1964;61: 1084-1103
54. Slavin RE, Dias MA, Sarai R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. A clinical-pathologic study of 33 patients. Cancer 1978;42:1747-59
55. Karp JE, Dick JD, Angelopulos C, Charache P, Green L, Burke PJ, Sarai R. Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Ran-domized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med 1986;81:237-42
56. Valenstein P, Schell WA. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomy-cosis. Arch Pathol Lab Med 1986;110:751-4
57. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: Correlation with nose cultures and antibiotic use. Ann Intern Med 1979;90:4-9
58. Gerson SL, Talbot GH, Lusk E, Hurwitz S, Strom BL, Cas-sileth PA. Invasive pulmonary aspergillosis in adult acute leukemia: Clinical clues to its diagnosis. J Clin Oncol 1985;3:1109-16
59. Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis com-licating neoplastic disease. Am J Med 1973;54:6-15
60. Newman KA, Schimpff SC, Young VM, Wiernik PH. Lessons learned from surveillance cultures in patients with acute nonlymphocytic leukemia. Usefulness for epidemi-olgic, preventive and therapeutic research. Am J Med 1981;70:423-31
61. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 1970;49:147-73
62. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986;81:249-54
63. Wingard JR, Dick JD, Merz WG, Sandford GR, Sarai R, Burns WH. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect Immun 1980;29:808-13
64. Mayer CF. Endemic panmyelotoxicosis in the Russian grainbelt. Part I. The clinical aspects of alimentary toxic aleukia (ATA). A comprehensive review. Military Surgeon 1953;113:173-89
65. 2 toxin on cultured human fetal esophagus. Carcinogenesis 1983;4:1101-7
66. Niaudet P, Beaurain G, Leibowitch J, Back J-F. In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunine. Clin Exp Immunol 1980;42:315-23
67. Kitahara M, Seth VK, Medoff G, Kobayashi GS. Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus. Antimicrob Agents Che-mother 1976;9:915-9
68. Shadomy S, Espinel-Ingroff A, Cartwright RY. Laboratory studies with antifungal agents: Susceptibility tests and bioassays. In: Lennette EH, Balows A, Hausier WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1985:991-9
69. Galgiani JN. Antifungal susceptibility tests. Antimicrob Agents Chemother 1987;31:1867-70